129 related articles for article (PubMed ID: 38547797)
1. Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform.
Soomherun N; Kreua-Ongarjnukool N; Niyomthai ST; Chumnanvej S
Colloids Surf B Biointerfaces; 2024 May; 237():113858. PubMed ID: 38547797
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive Effect of 5-Flurouracil Polymeric Hybrid PLGA-Lecithin Nanoparticles against Colon Dysplasia Model in Mice and Impact on p53 Apoptosis.
A Attia M; Enan ET; Hashish AA; M H El-Kannishy S; Gardouh AR; K Tawfik M; Faisal S; El-Mistekawy A; Salama A; Alomar SY; H Eltrawy A; Yagub Aloyouni S; Zaitone SA
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467560
[TBL] [Abstract][Full Text] [Related]
3. Anhydrous reverse micelle lecithin nanoparticles/PLGA composite microspheres for long-term protein delivery with reduced initial burst.
Chen L; Mei L; Feng D; Huang D; Tong X; Pan X; Zhu C; Wu C
Colloids Surf B Biointerfaces; 2018 Mar; 163():146-154. PubMed ID: 29291500
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of vinculin-targeted polymer-lipid nanoparticle as intracellular delivery vehicle.
Wang J; Ornek-Ballanco C; Xu J; Yang W; Yu X
Int J Nanomedicine; 2013; 8():39-46. PubMed ID: 23293518
[TBL] [Abstract][Full Text] [Related]
5. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
Jain S; Valvi PU; Swarnakar NK; Thanki K
Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
[TBL] [Abstract][Full Text] [Related]
6. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
[TBL] [Abstract][Full Text] [Related]
7. Targeting pentamidine towards CD44-overexpressing cells using hyaluronated lipid-polymer hybrid nanoparticles.
Andreana I; Chiapasco M; Bincoletto V; Digiovanni S; Manzoli M; Ricci C; Del Favero E; Riganti C; Arpicco S; Stella B
Drug Deliv Transl Res; 2024 Aug; 14(8):2100-2111. PubMed ID: 38709442
[TBL] [Abstract][Full Text] [Related]
8. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
9. Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer.
Du M; Ouyang Y; Meng F; Zhang X; Ma Q; Zhuang Y; Liu H; Pang M; Cai T; Cai Y
Int J Pharm; 2019 Apr; 561():274-282. PubMed ID: 30851393
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
[TBL] [Abstract][Full Text] [Related]
11. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
[TBL] [Abstract][Full Text] [Related]
12. Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.
Huang Q; Cai T; Li Q; Huang Y; Liu Q; Wang B; Xia X; Wang Q; Whitney JCC; Cole SPC; Cai Y
Drug Deliv; 2018 Nov; 25(1):1056-1066. PubMed ID: 29695174
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability and gastroprotective effect of ibuprofen through mixed polymer-lipid nanoparticles.
Al-Thamarani S; Gardouh A
Ther Deliv; 2021 May; 12(5):363-374. PubMed ID: 33849297
[No Abstract] [Full Text] [Related]
14. Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability.
Anwer MK; Ali EA; Iqbal M; Ahmed MM; Aldawsari MF; Saqr AA; Ansari MN; Aboudzadeh MA
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011397
[TBL] [Abstract][Full Text] [Related]
15. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
16. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
17. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
[TBL] [Abstract][Full Text] [Related]
18. A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs.
Li Q; Cai T; Huang Y; Xia X; Cole SPC; Cai Y
Nanomaterials (Basel); 2017 May; 7(6):. PubMed ID: 28554993
[TBL] [Abstract][Full Text] [Related]
19. Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids.
García-Díaz M; Foged C; Nielsen HM
Int J Pharm; 2015 Mar; 482(1-2):84-91. PubMed ID: 25445991
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]